Description

Rexobol is indicated for the treatment of antianemic conditions, including aplastic anemia, as well as hereditary angioedema and antithrombin III deficiency. It aids in stimulating red blood cell production, improving oxygen transport, and supporting recovery in patients with low blood cell counts or chronic anemia.
In cases of aplastic anemia, Rexobol helps enhance bone marrow activity to restore normal blood formation. For angioedema, it assists in reducing the frequency and severity of swelling episodes. Additionally, in antithrombin III deficiency, it contributes to maintaining proper blood flow and minimizing the risk of clot formation.
Through its anabolic and hematopoietic effects, Rexobol supports overall recovery, strength, and well-being in patients requiring such therapeutic interventions.